Literature DB >> 31434739

Sex-specific hepatic lipid and bile acid metabolism alterations in Fancd2-deficient mice following dietary challenge.

Elizabeth S Moore1, Erin K Daugherity1,2, David I Karambizi1, Bethany P Cummings1, Erica Behling-Kelly3, Deanna M W Schaefer4, Teresa L Southard1, Joseph W McFadden5, Robert S Weiss6.   

Abstract

Defects in the Fanconi anemia (FA) DNA damage-response pathway result in genomic instability, developmental defects, hematopoietic failure, cancer predisposition, and metabolic disorders. The endogenous sources of damage contributing to FA phenotypes and the links between FA and metabolic disease remain poorly understood. Here, using mice lacking the Fancd2 gene, encoding a central FA pathway component, we investigated whether the FA pathway protects against metabolic challenges. Fancd2 -/- and wildtype (WT) mice were fed a standard diet (SD), a diet enriched in fat, cholesterol, and cholic acid (Paigen diet), or a diet enriched in lipid alone (high-fat diet (HFD)). Fancd2 -/- mice developed hepatobiliary disease and exhibited decreased survival when fed a Paigen diet but not a HFD. Male Paigen diet-fed mice lacking Fancd2 had significant biliary hyperplasia, increased serum bile acid concentration, and increased hepatic pathology. In contrast, female mice were similarly impacted by Paigen diet feeding regardless of Fancd2 status. Upon Paigen diet challenge, male Fancd2 -/- mice had altered expression of genes encoding hepatic bile acid transporters and cholesterol and fatty acid metabolism proteins, including Scp2/x, Abcg5/8, Abca1, Ldlr, Srebf1, and Scd-1 Untargeted lipidomic profiling in liver tissue revealed 132 lipid species, including sphingolipids, glycerophospholipids, and glycerolipids, that differed significantly in abundance depending on Fancd2 status in male mice. We conclude that the FA pathway has sex-specific impacts on hepatic lipid and bile acid metabolism, findings that expand the known functions of the FA pathway and may provide mechanistic insight into the metabolic disease predisposition in individuals with FA.
© 2019 Moore et al.

Entities:  

Keywords:  DNA damage response; Fanconi anemia; Fanconi anemia complementation group D2 (FANCD2); cholestasis; cholesterol metabolism; fatty acid metabolism; lipid metabolism; liver metabolism; metabolic syndrome; nonalcoholic fatty liver disease

Mesh:

Substances:

Year:  2019        PMID: 31434739      PMCID: PMC6816084          DOI: 10.1074/jbc.RA118.005729

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  72 in total

Review 1.  Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity.

Authors:  Roger H Unger; Philipp E Scherer
Journal:  Trends Endocrinol Metab       Date:  2010-03-10       Impact factor: 12.015

2.  Interaction of bile salts with rat canalicular membrane vesicles: evidence for bile salt resistant microdomains.

Authors:  Christelle Guyot; Bruno Stieger
Journal:  J Hepatol       Date:  2011-05-19       Impact factor: 25.083

Review 3.  Cholesterol, sphingolipids, and glycolipids: what do we know about their role in raft-like membranes?

Authors:  Tomasz Róg; Ilpo Vattulainen
Journal:  Chem Phys Lipids       Date:  2014-11-01       Impact factor: 3.329

Review 4.  Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol.

Authors:  J M Ntambi
Journal:  J Lipid Res       Date:  1999-09       Impact factor: 5.922

5.  Distinct Metabolic Signature of Human Bladder Cancer Cells Carrying an Impaired Fanconi Anemia Tumor-Suppressor Signaling Pathway.

Authors:  Jayabal Panneerselvam; Guoxiang Xie; Raymond Che; Mingming Su; Jun Zhang; Wei Jia; Peiwen Fei
Journal:  J Proteome Res       Date:  2016-03-16       Impact factor: 4.466

6.  Gender- and age-related distinctions for the in vivo prooxidant state in Fanconi anaemia patients.

Authors:  Giovanni Pagano; Paolo Degan; Marco d'Ischia; Frank J Kelly; Federico V Pallardó; Adriana Zatterale; S Sema Anak; Ebru E Akisik; Gerardo Beneduce; Rita Calzone; Elena De Nicola; Christina Dunster; Ana Lloret; Paola Manini; Bruno Nobili; Anna Saviano; Emilia Vuttariello; Michel Warnau
Journal:  Carcinogenesis       Date:  2004-06-10       Impact factor: 4.944

7.  Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice.

Authors:  Scott Houghtaling; Cynthia Timmers; Meenakshi Noll; Milton J Finegold; Stephen N Jones; M Stephen Meyn; Markus Grompe
Journal:  Genes Dev       Date:  2003-07-31       Impact factor: 11.361

Review 8.  The Fanconi anaemia pathway: new players and new functions.

Authors:  Raphael Ceccaldi; Prabha Sarangi; Alan D D'Andrea
Journal:  Nat Rev Mol Cell Biol       Date:  2016-05-05       Impact factor: 94.444

9.  Gender-related differences in bile acid and sterol metabolism in outbred CD-1 mice fed low- and high-cholesterol diets.

Authors:  S D Turley; M Schwarz; D K Spady; J M Dietschy
Journal:  Hepatology       Date:  1998-10       Impact factor: 17.425

10.  Tunable regulation of CREB DNA binding activity couples genotoxic stress response and metabolism.

Authors:  Sang Hwa Kim; Anthony T Trinh; Michele Campaigne Larsen; Adam S Mastrocola; Colin R Jefcoate; Pierre R Bushel; Randal S Tibbetts
Journal:  Nucleic Acids Res       Date:  2016-07-18       Impact factor: 16.971

View more
  2 in total

Review 1.  Head and Neck Cancer Susceptibility and Metabolism in Fanconi Anemia.

Authors:  Tafadzwa Chihanga; Sara Vicente-Muñoz; Sonya Ruiz-Torres; Bidisha Pal; Mathieu Sertorio; Paul R Andreassen; Ruby Khoury; Parinda Mehta; Stella M Davies; Andrew N Lane; Lindsey E Romick-Rosendale; Susanne I Wells
Journal:  Cancers (Basel)       Date:  2022-04-18       Impact factor: 6.575

2.  The microbiome affects liver sphingolipids and plasma fatty acids in a murine model of the Western diet based on soybean oil.

Authors:  Sara C Di Rienzi; Elizabeth L Johnson; Jillian L Waters; Elizabeth A Kennedy; Juliet Jacobson; Peter Lawrence; Dong Hao Wang; Tilla S Worgall; J Thomas Brenna; Ruth E Ley
Journal:  J Nutr Biochem       Date:  2021-06-26       Impact factor: 6.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.